ICLR
ICLR
NASDAQ · Life Sciences Tools & Services

Icon Plc

$101.28
+0.93 (+0.93%)
Financial Highlights (FY 2026)
Revenue
7.86B
Net Income
750.96M
Gross Margin
29.5%
Profit Margin
9.6%
Rev Growth
+14.8%
D/E Ratio
0.36
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 29.5% 29.5% 48.1% 48.1%
Operating Margin 13.3% 11.9% 10.5% 12.7%
Profit Margin 9.6% 9.1% 7.4% 7.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 7.86B 6.85B 3.35B 2.67B
Gross Profit 2.32B 2.02B 1.61B 1.29B
Operating Income 1.04B 817.20M 353.31M 338.76M
Net Income 750.96M 588.99M 247.00M 186.41M
Gross Margin 29.5% 29.5% 48.1% 48.1%
Operating Margin 13.3% 11.9% 10.5% 12.7%
Profit Margin 9.6% 9.1% 7.4% 7.0%
Rev Growth +14.8% +14.8% -1.3% +12.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.12B 1.12B 6.18B 4.84B
Total Equity 3.11B 3.11B 4.58B 4.76B
D/E Ratio 0.36 0.36 1.35 1.02
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 1.51B 1.25B 599.26M 448.41M
Free Cash Flow 348.15M 219.69M